Funding for this research was provided by:
Received: 11 May 2020
Revised: 27 May 2020
Accepted: 5 June 2020
First Online: 22 June 2020
Compliance with ethical standards
: Dr. Nofzinger is the inventor, founder, and chief medical officer of Ebb Therapeutics, the company that developed and is commercializing the forehead cooling device used in this study. Drs Neylan and Mysliwiec have received research funding unrelated to this work (TCN: VA: RX001939; NIMH: R01MH115020; NIA: R01AG060477; R01AG064314).
: This study was approved by Campos Research and was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: All subjects provided informed consent prior to their inclusion in the study.
: No individuals are identified in this report.